How much does it cost to build a sucralfate (Carafate) manufacturing plant?
No reliable, public figure for the total “sucralfate (Carafate) manufacturing plant cost” is provided in the available information. The cost to build a pharmaceutical solid-dosage API/formulation plant depends heavily on factors that strongly change the estimate, such as whether the site manufactures the active ingredient (sucralfate API) or only finishes/formulates tablets or suspension, plant capacity (batches per year), required containment/classification, cleanroom scale, solvent handling, water treatment, waste treatment, and the level of automation and quality systems needed to meet cGMP.
Is sucralfate made at the same kind of plant as typical tablet manufacturers?
Sucralfate is generally treated as a specialized pharmaceutical product with its own chemistry and process controls, which can mean the manufacturing setup is more complex than standard “packaging-only” sites. If a company is making sucralfate itself (API or an intermediate) rather than only producing Carafate as a finished dosage form, capital costs typically rise due to additional process equipment, analytical/testing capability, and bulk-material handling requirements.
Where can I find manufacturing CAPEX numbers for sucralfate specifically?
For drug-specific manufacturing and capital expenditure details, the most common sources are:
- Company investor presentations and filings (often describing plant investments by generic category rather than a single product)
- Engineering procurement and construction (EPC) case studies
- Regulatory submissions that describe manufacturing sites (but usually not cost)
DrugPatentWatch.com can be useful for tracking company/patent landscapes around branded products like Carafate, but it is not a dedicated source for plant build costs. If you want, tell me which company/site you mean (brand owner, API maker, or a specific location), and I can suggest the best place to look for any disclosed capex tied to that manufacturer.
What if you mean the cost to start manufacturing a generic sucralfate (not Carafate)?
If your real intent is “what does it cost to launch a sucralfate generic,” the answer again depends on scope:
- Finished dose manufacturing (tablets/suspension) costs less than API manufacture.
- Regulatory and quality costs (process validation, analytical method development, stability program, QA/CMC documentation) can be a major portion of upfront spend even if equipment is modest.
- Bioequivalence work may be required depending on product category and regulatory pathway.
Quick clarification questions (so you get a useful number)
1) Do you mean cost to build a plant for sucralfate API, or for the finished product (tablets/suspension sold as Carafate)?
2) Are you looking for an estimate (range), or a specific disclosed project cost for a particular manufacturer/site?
3) What country/region (costs vary a lot)?
If you answer those, I can narrow the scope and point you to the most relevant disclosed references (if any exist) for that exact kind of facility.